Shannon Gwin Mitchell
Overview
Explore the profile of Shannon Gwin Mitchell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitchell S, Gryczynski J, Worley D, Asche S, Truitt A, Rindal D
Implement Res Pract
. 2025 Feb;
6:26334895251319810.
PMID: 39931509
Background: De-implementing non-effective or even harmful practices in healthcare is sometimes necessary, as has been the case with opioid prescribing in dentistry over the past decade. One approach to practice...
2.
Blue T, Gordon M, Vocci F, Fishman M, Mitchell S, Wenzel K
J Addict Med
. 2025 Jan;
PMID: 39888715
Objectives: This study aimed to compare participants' experiences on two different formulations of extended-release buprenorphine. Methods: Participants were part of a larger parent study comparing Brixadi™ (extended-release buprenorphine), hereafter called...
3.
Metz V, Bendtsen M, Arya S, Francis J, Ghosh A, Haller D, et al.
J Adolesc Health
. 2024 Dec;
76(1):9-15.
PMID: 39694600
No abstract available.
4.
Molfenter T, Ducharme L, Stein L, Belenko S, Mitchell S, Watson D, et al.
Implement Res Pract
. 2024 Dec;
5:26334895241297278.
PMID: 39650595
Background: The outcomes of planned implementation efforts have been mixed, with some applications failing to achieve the desired change or impact. While reasons for mixed findings in implementation research are...
5.
Terplan M, OGrady K, Monico L, Schwartz R, Gryczynski J, Fishman M, et al.
Subst Use Addctn J
. 2024 Sep;
46(1):72-77.
PMID: 39297332
Background: We assess adverse events (AEs) following medication initiation for adolescents and young adults with opioid use disorder (OUD). Methods: This is a secondary analysis of a clinical trial of...
6.
Monico L, Fletcher J, Ross T, Schwartz R, Fishman M, Gryczynski J, et al.
J Subst Use Addict Treat
. 2024 Mar;
162:209334.
PMID: 38531508
Background: The opioid epidemic in the United States has not spared youth or young adults, as evidenced by a six-fold increase in opioid use disorder (OUD) diagnoses in the last...
7.
Hochstatter K, Nordeck C, Mitchell S, Schwartz R, Welsh C, Gryczynski J
Prev Med Rep
. 2023 Dec;
36:102494.
PMID: 38116282
Polysubstance use is becoming increasingly common and presents several harms. This study aimed to examine the association of comorbid cocaine, alcohol (binge drinking), and sedative use with mortality among hospitalized...
8.
Burruss-Cousins K, Mitchell S, Gryczynski J, Whitter M, Fuller D, Ibrahim A, et al.
J Subst Use Addict Treat
. 2023 Dec;
157:209265.
PMID: 38103832
Introduction: People seeking treatment at opioid treatment programs (OTPs) can face admission delays. Interim methadone (IM) treatment, an effective approach to expedite admissions when programs lack sufficient counseling staff, has...
9.
Fuller D, Gryczynski J, Schwartz R, Halsted C, Mitchell S, Whitter M
J Subst Use Addict Treat
. 2023 Dec;
158:209214.
PMID: 38042301
Introduction: In the United States, methadone treatment may only be provided through opioid treatment programs (OTPs), which operate under a complex system of federal and state regulations. During the pandemic,...
10.
Hogue A, Satcher M, Drazdowski T, Hagaman A, Hibbard P, Sheidow A, et al.
J Subst Use Addict Treat
. 2023 Nov;
157:209217.
PMID: 37981242
Introduction: This article proposes a taxonomy of linkage facilitation services used to help persons with opioid use disorder access treatment and recovery resources. Linkage facilitation may be especially valuable for...